CRISPR

CRISPR2-dmd

ID

ZDB-CRISPR-210202-1

Name

CRISPR2-dmd

Previous Names

None

Target

Sequence

5' - AGGCCAAAATGCAGATGTCA - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

The PAM site was AGG at the 3' end.

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
pc39	dmd

Expression

Gene expression in Wild Types + CRISPR2-dmd

No data available

Phenotype

Phenotype resulting from CRISPR2-dmd

No data available

Phenotype of all Fish created by or utilizing CRISPR2-dmd

Phenotype	Fish	Conditions	Figures
muscle cell dmd expression absent, abnormal	dmd^pc39/pc39	standard conditions	FIGURE 1 from Berger et al., 2020
muscle cell decreased amount, abnormal	dmd^pc39/pc39	chemical treatment by environment: 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid	Fig. 2 from Berger et al., 2020
muscle cell retracted, abnormal	dmd^pc39/pc39	standard conditions	FIGURE 1 from Berger et al., 2020
muscle cell decreased amount, abnormal	dmd^pc39/pc39	standard conditions	Fig. 2 from Berger et al., 2020
muscle contraction decreased magnitude, abnormal	dmd^pc39/pc39	chemical treatment by environment: 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid	Fig. 3 from Berger et al., 2020
muscle contraction decreased magnitude, abnormal	dmd^pc39/pc39	standard conditions	Fig. 3 from Berger et al., 2020

Citations